Showing results (21-30 of 247) with videos related to
Sort By:
Pageof 25
Trends in Pharmacological Sciences|May 23, 2024
Defeating MYC with drug combinations or dual-targeting drugsPhilip E Thompson, Jake ShorttEpigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael BotsScience Advances|December 18, 2024
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precisionCarolyn Shembrey, Ray Yang, Joshua Casan, et al.Nature Communications|April 28, 2015
Manipulation of B-cell responses with histone deacetylase inhibitorsMichaela Waibel, Ailsa J Christiansen, Margaret L Hibbs, et al.Investigational New Drugs|December 17, 2010
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectMichael Dickinson, Ricky W Johnstone, H Miles PrinceCell Cycle (Georgetown, Tex.)|May 22, 2004
Histone-deacetylase inhibitors for the treatment of cancerRalph K Lindemann, Brian Gabrielli, Ricky W JohnstoneMolecular Cancer Therapeutics|June 11, 2009
Epigenetics in cancer: targeting chromatin modificationsLeigh Ellis, Peter W Atadja, Ricky W JohnstoneImmunological Reviews|November 6, 2007
From cancer immunosurveillance to cancer immunotherapyJohn Stagg, Ricky W Johnstone, Mark J SmythAdvances in Cancer Research|October 24, 2012
Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activityGeoffrey M Matthews, Andrea Newbold, Ricky W JohnstoneMolecular Cancer Therapeutics|July 14, 2016
BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family MembersSimon J Hogg, Andrea Newbold, Stephin J Vervoort, et al.Pageof 25